Endothelial cell Pannexin1 modulates severity of ischemic stroke by regulating cerebral inflammation and myogenic tone

Ischemic stroke is a leading cause of morbidity and mortality in the US; however, there currently exists only one effective acute pharmacological therapeutic intervention. Purinergic signaling has been shown to regulate vascular function and pathological processes, including inflammation and arteria...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:JCI Insight
Egile Nagusiak: Good, Miranda E, Eucker, Stephanie A., Li, Jun, Bacon, Hannah M., Lang, Susan M., Butcher, Joshua T., Johnson, Tyler J., Gaykema, Ronald P., Patel, Manoj K., Zuo, Zhiyi, Isakson, Brant E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Clinical Investigation 2018
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5926909/
https://ncbi.nlm.nih.gov/pubmed/29563335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.96272
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak